Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 58

1.

Influence of ergonomic layout of musician chairs on posture and seat pressure in musicians of different playing levels.

Ohlendorf D, Maurer C, Bolender E, Kocis V, Song M, Groneberg DA.

PLoS One. 2018 Dec 11;13(12):e0208758. doi: 10.1371/journal.pone.0208758. eCollection 2018.

2.

Risk factors for the development of brain metastases in patients with HER2-positive breast cancer.

Maurer C, Tulpin L, Moreau M, Dumitrescu C, de Azambuja E, Paesmans M, Nogaret JM, Piccart MJ, Awada A.

ESMO Open. 2018 Oct 24;3(6):e000440. doi: 10.1136/esmoopen-2018-000440. eCollection 2018.

3.

Single-agent PARP inhibitors for the treatment of patients with BRCA-mutated HER2-negative metastatic breast cancer: a systematic review and meta-analysis.

Poggio F, Bruzzone M, Ceppi M, Conte B, Martel S, Maurer C, Tagliamento M, Viglietti G, Del Mastro L, de Azambuja E, Lambertini M.

ESMO Open. 2018 Jun 20;3(4):e000361. doi: 10.1136/esmoopen-2018-000361. eCollection 2018.

4.

International challenge to model the long-range transport of radioxenon released from medical isotope production to six Comprehensive Nuclear-Test-Ban Treaty monitoring stations.

Maurer C, Baré J, Kusmierczyk-Michulec J, Crawford A, Eslinger PW, Seibert P, Orr B, Philipp A, Ross O, Generoso S, Achim P, Schoeppner M, Malo A, Ringbom A, Saunier O, Quèlo D, Mathieu A, Kijima Y, Stein A, Chai T, Ngan F, Leadbetter SJ, De Meutter P, Delcloo A, Britton R, Davies A, Glascoe LG, Lucas DD, Simpson MD, Vogt P, Kalinowski M, Bowyer TW.

J Environ Radioact. 2018 Dec;192:667-686. doi: 10.1016/j.jenvrad.2018.01.030. Epub 2018 Mar 8.

5.

Endocrine therapy and palbociclib within a compassionate use program in heavily pretreated hormone receptor-positive, HER2-negative metastatic breast cancer.

Maurer C, Ferreira AR, Martel S, Lambertini M, Pondé N, Aftimos P, de Azambuja E, Piccart M.

Breast. 2018 Jun;39:14-18. doi: 10.1016/j.breast.2018.02.027. Epub 2018 Mar 7.

PMID:
29474991
6.

Strength improvements through occlusal splints? The effects of different lower jaw positions on maximal isometric force production and performance in different jumping types.

Maurer C, Heller S, Sure JJ, Fuchs D, Mickel C, Wanke EM, Groneberg DA, Ohlendorf D.

PLoS One. 2018 Feb 23;13(2):e0193540. doi: 10.1371/journal.pone.0193540. eCollection 2018.

7.

Risk of adverse events with the addition of targeted agents to endocrine therapy in patients with hormone receptor-positive metastatic breast cancer: A systematic review and meta-analysis.

Martel S, Bruzzone M, Ceppi M, Maurer C, Ponde NF, Ferreira AR, Viglietti G, Del Mastro L, Prady C, de Azambuja E, Lambertini M.

Cancer Treat Rev. 2018 Jan;62:123-132. doi: 10.1016/j.ctrv.2017.09.009. Epub 2017 Nov 3. Review.

PMID:
29108713
8.

Male breast cancer: finding the way in this uncommon path.

Maurer C, Martel S, de Azambuja E.

ESMO Open. 2017 Mar 16;2(1):e000169. doi: 10.1136/esmoopen-2017-000169. eCollection 2017. No abstract available.

9.

Breast cancer treatment-induced cardiotoxicity.

Martel S, Maurer C, Lambertini M, Pondé N, De Azambuja E.

Expert Opin Drug Saf. 2017 Sep;16(9):1021-1038. doi: 10.1080/14740338.2017.1351541. Epub 2017 Jul 18. Review.

PMID:
28697311
10.

New agents for endocrine resistance in breast cancer.

Maurer C, Martel S, Zardavas D, Ignatiadis M.

Breast. 2017 Aug;34:1-11. doi: 10.1016/j.breast.2017.04.007. Epub 2017 Apr 24. Review.

PMID:
28448864
11.

Minimal Residual Disease Assessment Improves Prediction of Outcome in Patients With Chronic Lymphocytic Leukemia (CLL) Who Achieve Partial Response: Comprehensive Analysis of Two Phase III Studies of the German CLL Study Group.

Kovacs G, Robrecht S, Fink AM, Bahlo J, Cramer P, von Tresckow J, Maurer C, Langerbeins P, Fingerle-Rowson G, Ritgen M, Kneba M, Döhner H, Stilgenbauer S, Klapper W, Wendtner CM, Fischer K, Hallek M, Eichhorst B, Böttcher S.

J Clin Oncol. 2016 Nov 1;34(31):3758-3765. doi: 10.1200/JCO.2016.67.1305.

PMID:
27573660
12.

The CREB-binding protein affects the circadian regulation of behaviour.

Maurer C, Winter T, Chen S, Hung HC, Weber F.

FEBS Lett. 2016 Sep;590(18):3213-20. doi: 10.1002/1873-3468.12336. Epub 2016 Aug 28.

13.

First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial.

Eichhorst B, Fink AM, Bahlo J, Busch R, Kovacs G, Maurer C, Lange E, Köppler H, Kiehl M, Sökler M, Schlag R, Vehling-Kaiser U, Köchling G, Plöger C, Gregor M, Plesner T, Trneny M, Fischer K, Döhner H, Kneba M, Wendtner CM, Klapper W, Kreuzer KA, Stilgenbauer S, Böttcher S, Hallek M; international group of investigators; German CLL Study Group (GCLLSG).

Lancet Oncol. 2016 Jul;17(7):928-942. doi: 10.1016/S1470-2045(16)30051-1. Epub 2016 May 20.

PMID:
27216274
14.

International challenge to predict the impact of radioxenon releases from medical isotope production on a comprehensive nuclear test ban treaty sampling station.

Eslinger PW, Bowyer TW, Achim P, Chai T, Deconninck B, Freeman K, Generoso S, Hayes P, Heidmann V, Hoffman I, Kijima Y, Krysta M, Malo A, Maurer C, Ngan F, Robins P, Ross JO, Saunier O, Schlosser C, Schöppner M, Schrom BT, Seibert P, Stein AF, Ungar K, Yi J.

J Environ Radioact. 2016 Jun;157:41-51. doi: 10.1016/j.jenvrad.2016.03.001. Epub 2016 Mar 19.

PMID:
26998569
15.

Bendamustine and rituximab in combination with lenalidomide in patients with chronic lymphocytic leukemia.

Maurer C, Pflug N, Bahlo J, Kluth S, Rhein C, Cramer P, Gross-Ophoff C, Langerbeins P, Fink AM, Eichhorst B, Kreuzer KA, Fischer N, Tausch E, Stilgenbauer S, Böttcher S, Döhner H, Kneba M, Dreyling M, Binder M, Hallek M, Wendtner CM, Bergmann M, Fischer K; German CLL Study Group.

Eur J Haematol. 2016 Sep;97(3):253-60. doi: 10.1111/ejh.12714. Epub 2016 Feb 9.

PMID:
26643449
16.

Changes in cortical activity measured with EEG during a high-intensity cycling exercise.

Enders H, Cortese F, Maurer C, Baltich J, Protzner AB, Nigg BM.

J Neurophysiol. 2016 Jan 1;115(1):379-88. doi: 10.1152/jn.00497.2015. Epub 2015 Nov 4.

17.

Footwear Decreases Gait Asymmetry during Running.

Hoerzer S, Federolf PA, Maurer C, Baltich J, Nigg BM.

PLoS One. 2015 Oct 21;10(10):e0138631. doi: 10.1371/journal.pone.0138631. eCollection 2015.

18.

Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial.

Fischer K, Bahlo J, Fink AM, Goede V, Herling CD, Cramer P, Langerbeins P, von Tresckow J, Engelke A, Maurer C, Kovacs G, Herling M, Tausch E, Kreuzer KA, Eichhorst B, Böttcher S, Seymour JF, Ghia P, Marlton P, Kneba M, Wendtner CM, Döhner H, Stilgenbauer S, Hallek M.

Blood. 2016 Jan 14;127(2):208-15. doi: 10.1182/blood-2015-06-651125. Epub 2015 Oct 20.

19.

Influence of the Lower Jaw Position on the Running Pattern.

Maurer C, Stief F, Jonas A, Kovac A, Groneberg DA, Meurer A, Ohlendorf D.

PLoS One. 2015 Aug 13;10(8):e0135712. doi: 10.1371/journal.pone.0135712. eCollection 2015.

20.

[Imported histoplasmosis].

Stete K, Kern WV, Rieg S, Serr A, Maurer C, Tintelnot K, Wagner D.

Dtsch Med Wochenschr. 2015 Jun;140(12):913-6. doi: 10.1055/s-0041-102040. Epub 2015 Jun 12. German.

PMID:
26069920

Supplemental Content

Loading ...
Support Center